Fig. 2From: Highly multiplexed targeted sequencing strategy for infectious disease surveillanceAnalytical specificity of the designed MIP panel. (A) DNA extracts (0.1–10 ng) from individual pathogens included in the panel were tested with the assay to assess specificity and cross-reactivity (n = 4). (B) DNA extracts (0.1–10 ng) from species not included in the design were additionally tested to challenge the specificity of the method (n = 3)Back to article page